Healy James
- SEC CIK
- 0001245624
No open-market purchases or sales filed in the past year.
Current role at each company
- BIOA BioAge Labs, Inc.Directoras of Jun 12, 2026
- RAPP Rapport Therapeutics, Inc.Directoras of Jun 10, 2026
- SPTX Seaport Therapeutics, Inc.Directoras of May 4, 2026
- YMAB Y-mAbs Therapeutics, Inc.Directoras of Sep 18, 2025
- NTRA Natera, Inc.Directoras of Apr 29, 2025
Show 7 more companies
- BOLT Bolt Biotherapeutics, Inc.Directoras of Jun 14, 2024
- KRTX Karuna Therapeutics, Inc.Directoras of Mar 18, 2024
- AVBP ArriVent BioPharma, Inc.Directoras of Jan 31, 2024
- CINC CinCor Pharma, Inc.Director, 10% Owneras of Feb 27, 2023
- VERA Vera Therapeutics, Inc.10% Owneras of Feb 8, 2023
- CHRS Coherus Oncology, Inc.Directoras of Feb 11, 2022
- JBIO Jade Biosciences, Inc.10% Owneras of Jul 6, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Healy James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BIOA BioAge Labs, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 (view filing) | Sep 27 | Same day | Healy JamesDirector | PPurchase | +666.7K | $18.00 | +$12.0M | New position26.5K after | 5 lots |
RAPP Rapport Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 (view filing) | Jul 1 | 2 days | Healy JamesDirector | PPurchase | +44.0K | $24.52 | +$1.08M | New position40.9K after | 12 lots |
| Jun 10, 2024 (view filing) | Jun 10 | Same day | Healy JamesDirector | PPurchase | +558.8K | $17.00 | +$9.50M | New position25.5K after | 5 lots |
AVBP ArriVent BioPharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 (view filing) | Jan 30 | 1 day | Healy JamesDirector | PPurchase | +444.4K | $18.00 | +$8.00M | +35.5%1.70M after |
NTRA Natera, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 (view filing) | Dec 13 | 9 daysLate | Healy JamesDirector | SSale | −644.0K | $58.75 | −$37.8M | −100.0%0 after | |
| Jan 18, 2023 (view filing) | Nov 16, 2022 | 63 daysLate | Healy JamesDirector | SSale | −2.40K | $37.71 | −$90.5K | −100.0%0 after | |
| Jul 26, 2021 (view filing) | Jul 22 | 4 days | Healy JamesDirector | PPurchase | +2.40K | $113.00 | +$271.2K | New position2.40K after |
CINC CinCor Pharma, Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 (view filing)9:15 PM ET | Nov 28, 2022 | 91 daysLate | Healy James and 4 othersDirector, 10% Owner | SSale | −6.00K | $14.32 | −$85.9K | −100.0%0 after | |
| Aug 15, 2022 (view filing) | Aug 11 | 4 days | Healy JamesDirector, 10% Owner | PPurchase | +506.0K | $30.00 | +$15.2M | New position6.00K after | 2 lots |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Healy JamesDirector, 10% Owner | PPurchase | +325.0K | $16.00 | +$5.20M | +6.2%5.57M after |
VERA Vera Therapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 (view filing)6:29 PM ET | Feb 6 | 2 days | Katabi Maha and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +285.7K | $7.00 | +$2.00M | +9.0%3.47M after | |
| Feb 14, 2022 (view filing)6:17 PM ET | Feb 10 | 4 days | Katabi Maha and 3 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +266.7K | $15.00 | +$4.00M | +9.1%3.18M after |
KRTX Karuna Therapeutics, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 (view filing) | Jan 13 | 4 days | Healy JamesDirector | SSale | −6.03K | $199.90 | −$1.20M | −100.0%0 after | |
| Jul 1, 2022 (view filing) | Jun 29-30 | 2 days | Healy JamesDirector | PPurchase | +120.0K | $122.80 | +$14.7M | +6.1%2.07M after | 6 lots |
| Apr 14, 2022 (view filing) | Apr 1 | 13 daysLate | Healy JamesDirector | PPurchase | +47 | $129.38 | +$6.08K | +7.4%683 after | |
| Jul 7, 2021 (view filing) | Jul 2 | 5 days | Healy JamesDirector | PPurchase | +636 | $117.80 | +$74.9K | New position636 after |
CHRS Coherus Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2021 (view filing) | Sep 27-29 | 2 days | Healy JamesDirector | SSaleCommon Stock, $0.0001 par value | −434.6K | $16.68 | −$7.25M | −100.0%0 after | 3 lots |
JBIO Jade Biosciences, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 (view filing)4:28 PM ET | Jul 2 | 4 days | Healy James and 2 others10% Owner | PPurchase | +357.1K | $14.00 | +$5.00M | +10.5%3.76M after | Duplicate filing |